Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 55222401000001115 | Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 59479801000001119 | Pandemrix vaccine emulsion and suspension for emulsion for injection (GlaxoSmithKline UK Ltd) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has excipient | Thimerosal | false | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Is a | Influenza H1N1 vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection 500 dose | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | false | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has AMP | Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has dispensed dose form | Suspension and emulsion for emulsion for injection | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Has specific active ingredient | Influenza virus split virion (H1N1 strain) inactivated | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | Discontinued indicator | Discontinued AMPP(qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Pandemrix (H1N1) vaccine (split virion, inactivated, adjuvanted) suspension and emulsion for emulsion for injection (GlaxoSmithKline) 500 dose 500x0.5ml dose(0.25ml+0.25ml) | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR